Skip to main content

Peer Review reports

From: Clinical trials with cannabis medicines—guidance for ethics committees, governance officers and researchers to streamline ethics applications and ensuring patient safety: considerations from the Australian experience

Original Submission
13 May 2020 Submitted Original manuscript
6 Jul 2020 Reviewed Reviewer Report - alastair matheson
10 Jul 2020 Reviewed Reviewer Report - Jonathan Silcock
12 Aug 2020 Author responded Author comments - Jennifer Martin
Resubmission - Version 2
12 Aug 2020 Submitted Manuscript version 2
1 Sep 2020 Reviewed Reviewer Report - Jonathan Silcock
6 Sep 2020 Reviewed Reviewer Report - alastair matheson
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
3 Nov 2020 Editorially accepted
17 Nov 2020 Article published 10.1186/s13063-020-04862-6

You can find further information about peer review here.

Back to article page